Abstract

BackgroundRecently, IL-1 is implicated in the pathogenesis of autoinflammatory syndromes, which characterized by rash, fever, systemic polyarthritis and neurological comorbidity. Recently, IL-1 is being accepted as a therapeutic target of...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call